SeqLL, Inc. (SQL)
| Market Cap | 9.75M |
| Revenue (ttm) | 196,744 |
| Net Income (ttm) | -3.23M |
| Shares Out | 11.89M |
| EPS (ttm) | -0.36 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 32,008 |
| Open | 0.820 |
| Previous Close | 0.820 |
| Day's Range | 0.755 - 0.858 |
| 52-Week Range | 0.610 - 5.800 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 3.06 (+273.2%) |
| Earnings Date | Aug 12, 2022 |
About SQL
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government ... [Read more...]
Financial Performance
In 2021, SeqLL's revenue was $209,995, a decrease of -36.27% compared to the previous year's $329,495. Losses were -$3.70 million, 254.3% more than in 2020.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for SQL stock is "Buy." The 12-month stock price forecast is 3.06, which is an increase of 273.17% from the latest price.
News
SeqLL Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements
BILLERICA, Mass., June 24, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (NASDAQ: SQL and SQLLW) (“SeqLL” or the “Company”), a technology company providing life sciences instrumentation and research services in c...
SeqLL's Single-Molecule Nucleosome Imaging Method Published in Peer Reviewed Cell Reports Journal
BILLERICA, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in coll...
SeqLL Provides First Quarter 2022 Financial Results and a Corporate Update
BILLERICA, Mass., May 13, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in colla...
6 Stocks Halted In Thursday's Session
A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It's a measure put in place to help restore and bring ...
SeqLL Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
BILLERICA, Mass., March 30, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in col...
SeqLL to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
BILLERICA, Mass., March 24, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for co...
SeqLL Announces Formation of Scientific Advisory Board
BILLERICA, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services for co...
SeqLL Inc. Announces Closing of Underwriters' Option to Purchase Additional Shares of Common Stock in Connection with...
WOBURN, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL; SQLLW), a development-stage life sciences instrumentation and research services company engaged in th...
SeqLL Announces Publication of a New Single-Cell Epitranscriptomic Method Powered by SeqLL's tSMS® Platform
Method developed by leading researchers at the Bernstein Laboratory and SeqLL Inc.
